8.24
Harvard Bioscience Inc (HBIO) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
9.50%
22.73
|
20.75 | 23.73 | 20.59 | 20.45 |
| Cost Of Revenue |
18.63%
10.10
|
8.511 | 9.563 | 8.57 | 8.917 |
| Gross Profit |
3.15%
12.63
|
12.24 | 14.17 | 12.02 | 11.53 |
|
|
1.42%
13.61
|
13.42 | 12.46 | 11.82 | 12.35 |
| Operating Income/Loss |
16.70%
-0.978
|
-1.174 | 1.71 | 0.197 | -0.819 |
| Nonoperating Income/Loss |
10.08%
-1.918
|
-2.133 | -4.914 | -1.331 | -1.435 |
| Income/Loss From Continuing Operations Before Tax |
12.43%
-2.896
|
-3.307 | -3.204 | -1.134 | -2.254 |
| Income Tax Expense/Benefit |
88.03%
0.014
|
0.117 | -0.357 | 0.097 | 0.028 |
| Net Income/Loss |
15.01%
-2.91
|
-3.424 | -2.847 | -1.231 | -2.282 |
| Basic Average Shares |
1.18%
4.526
|
4.473 | - | 44.56 | 44.30 |
| Diluted Average Shares |
1.18%
4.526
|
4.473 | - | 44.56 | 44.30 |
| Basic Earnings Per Share |
16.88%
-0.64
|
-0.77 | - | -0.03 | -0.05 |
| Diluted Earnings Per Share |
16.88%
-0.64
|
-0.77 | - | -0.03 | -0.05 |
자본화:
|
볼륨(24시간):